To ascertain the prognostic significance of tumor hormone receptor status in premenopausal patients with node-negative breast cancer, a retrospective review of 199 patients who met these criteria was conducted. Of these 199 patients, estrogen receptor (ER) data were available for 147. One hundred fo
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma
β Scribed by Victor R. Grann; Andrea B. Troxel; Naseem J. Zojwalla; Judith S. Jacobson; Dawn Hershman; Alfred I. Neugut
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 178 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND It has been established that pregnancy protects against breast carcinoma, and animal models have shown that human chorionic gonadotropin (hCG) mimics this effect by inhibiting the initiation and progression of experimental breast carcinoma. Luteinizing hormone (LH)/hCG re
## Abstract ## BACKGROUND Although overall survival for invasive breast carcinoma remains high, black women experience poorer survival than whites. Less is known about the survival of Hispanics and Asians, who may share clinical and socioeconomic risk factors similar to blacks. To better understan
## Abstract ## BACKGROUND. To the authors' knowledge, few studies have addressed racial disparities in the survival of patients with colon cancer by adequately incorporating treatment and socioeconomic factors in addition to patient and tumor characteristics. ## METHODS. The authors studied a na
## Abstract ## BACKGROUND. Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of populationβbased access to new agents for the treatment of MBC. ##